Choi, Yonghyun
Jang, Yerin
Lee, Hee-Young
Choi, Jonghoon
Funding for this research was provided by:
National Research Foundation of Korea (RS-2024-00459728)
Article History
Received: 15 January 2026
Accepted: 15 February 2026
First Online: 22 February 2026
Declarations
:
: Dr. Jonghoon Choi is the CEO and the Founder, Dr. Hee-Young Lee is the CSO and Dr. Yonghyun Choi is the CTO of the Feynman Institute of Technology at the Nanomedicine Corp, Seoul, Republic of Korea.